The global pharmacovigilance market is on a strong growth trajectory, with market revenue projected to expand from USD 9,000.0 million in 2025 to an estimated USD 20,902.9 million by 2035, reflecting a CAGR of 8.8%. This surge highlights the increasing importance of drug safety monitoring as the pharmaceutical industry continues to innovate. In 2024, the …
Category Archives: Press Release
Global Brain Biomarkers Market is expected to surpass 11,557.3 Million by 2033 | FMI
The global brain biomarkers market is poised for remarkable growth, fueled by the escalating prevalence of neurological disorders and rapid technological advancements. A recent market analysis reveals that the sector, valued at USD 8,516.7 million in 2023, is projected to reach USD 11,557.3 million by 2033, growing at a Compound Annual Growth Rate (CAGR) of …
Global Late-Stage Chronic Kidney Disease Therapeutics Market to Surpass at a remarkable CAGR of 11.6% from 2022 to 2032 Amid Rising CKD Prevalence | FMI
The global late-stage chronic kidney disease therapeutics market is witnessing significant growth, driven by the increasing prevalence of chronic kidney disease worldwide. Valued at approximately USD 4.7 billion in 2019, the market is set to surpass USD 11.1 billion by 2027, expanding at a remarkable CAGR of 11.6% from 2022 to 2032. CKD has emerged …
Peptide Receptor Radionuclide Therapy Market to Hit USD 1300 Million by 2033 Amid Rising Adoption of Advanced Therapies | FMI Report
The global peptide receptor radionuclide therapy market is projected to experience remarkable expansion, with its value anticipated to grow from USD 591.83 million in 2023 to USD 1300 million by 2033. This represents a compound annual growth rate (CAGR) of 8.2% over the forecast period. The rising demand for PRRT is driven by advancements in …
Global Next Generation Infusion Pump Market to Reach USD 8509 Million by 2032, Driven by Advanced Safety and Efficiency Features | FMI
The global next generation infusion pump market is on a steady growth trajectory, projected to expand from USD 5,059.7 million in 2022 to over USD 8,509 million by 2032, reflecting a CAGR of 4.8% during the forecast period. The increasing adoption of smart healthcare technologies, driven by the need for enhanced patient safety, workflow efficiency, …
Global Neuronavigation Systems Market to Reach USD 4794.5 Million by 2032 amid Rising Demand for Precision Neurosurgery | FMI
The global neuronavigation systems market is set for remarkable expansion, with projections estimating a market value of USD 4,794.5 million by 2032, up from USD 2,120.0 million in 2022. This surge is driven by a compound annual growth rate (CAGR) of 7.7% over the forecast period, underscoring the rising adoption of neuronavigation systems in neurosurgical …
Global Hyperbaric Oxygen Therapy Devices Market Poised for Significant Growth, Expected to Reach USD 6,352.4 Million by 2035
The global hyperbaric oxygen therapy devices market is set to witness substantial growth in the coming years. According to recent market projections, the HBOT market is expected to reach USD 3,827.6 million by 2025 and continue expanding at a steady compound annual growth rate (CAGR) of 5.2%, ultimately reaching USD 6,352.4 million by 2035. In …
Neurointerventional Device Market Poised for Steady Growth is expected to reach USD 4,477.6 Million by 2035
The neurointerventional device market is expected to witness significant growth in the coming decade, with projections indicating a rise from USD 2,824.2 million in 2025 to USD 4,477.6 million by 2035, reflecting a steady compound annual growth rate (CAGR) of 4.7%. This growth trajectory underscores the increasing demand for advanced medical solutions for neurovascular diseases …
Companion Animal Drugs Market Poised for Remarkable Growth to reach USD 29,329.2 million by 2034 Driven by Innovations in Precision Medicine | FMI
The global companion animal drugs market is experiencing an unprecedented surge, with projections estimating it will reach USD 16,131.2 million by 2024. This figure is expected to grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2034, ultimately reaching a market value of USD 29,329.2 million by 2034. This significant growth …
Transformative Growth Expected in the Respiratory Inhaler Devices Market to reach USD 63.66 Billion by 2035
The global respiratory inhaler devices market is on the cusp of significant transformation over the next decade, driven by a rising incidence of respiratory diseases, technological advancements, and changing healthcare landscapes. From 2025 to 2035, the market is set to experience notable growth, with projections indicating a steady expansion at a compound annual growth rate …